We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
Given its strong share price performance, we think it's worthwhile for Cardiol Therapeutics shareholders to consider whether its cash burn is concerning. For the purpose of ...
Simply Wall St. via Yahoo
10 hours ago